Total Funding
32
42
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
122816
Hemu Gene is a gene therapy technology developer. It has two gene editing platforms: lentivirus, CRISPR and Cas.
About the Company
Hemu Gene develops gene therapy technology to treat hemoglobin disease. With independent research and development capabilities, a reliable quality management system, and two main gene editing platforms—lentivirus and CRISPR/Cas—Hemu Gene continues to focus on the study, creation, and use of gene therapy vectors and genetic engineering
technology. The company has set up additional hematopoietic stem gene therapy production lines and is actively engaged in international clinical collaboration and international registration declaration.
